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How do we treat VEO-IBD?
• No treatment guidelines available.
• Few small case studies.
• Disease in very young is often severe at diagnosis.
• Cautious about surgery because extensive colonic disease has a tendency to extend to small bowel CD.
• Treatment may ultimately be based on genetic defects found in this patient group. Years of Study 2000-01 1998-99 1993-2004 2002-03 1998-2000 1998-2000 1994-2005 Sample Size 
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Case 1 -IL10R Pathway
• Antibiotics, intravenous immunoglobulins, steroids, anakinra, sulfasalazine and azathioprine were unsuccessful.
• Required diversion ostomyissues with poor wound healing.
• Weekly Joint injections. • Receptor IL10R has two subunits:
• Alpha (A / 1) -required for IL10
• Beta (B / 2) -required for IL10, -22, -26
• Acts through JAK1, TYK2, and STAT3 (all identified in IBD GWAS)
• Defects in IL10R A/B and IL10 have been identified • 180,000 exons found in the human genome.
• 
